相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy
Ting Martin Ma et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity
Ciro Franzese et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2021)
Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial
Elton Trigo Teixeira Leite et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, 3 trial
Per Fransson et al.
LANCET ONCOLOGY (2021)
Primary Endpoint Analysis of a Randomized Phase III Trial of Hypofractionated vs. Conventional Post-Prostatectomy Radiotherapy: NRG Oncology GU003
M.K. Buyyounouski et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial
Ting Martin Ma et al.
BMC CANCER (2021)
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Pirus Ghadjar et al.
EUROPEAN UROLOGY (2021)
Stereotactic Body Radiation Therapy to the Prostate Bed: Results of a Phase 1 Dose-Escalation Trial
Sagus Sampath et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Ten-Year Outcomes of Moderately Hypofractionated Salvage Postprostatectomy Radiation Therapy and External Validation of a Contemporary Multivariable Nomogram for Biochemical Failure
Stephen Chin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
A Nationwide Persistent Underutilization of Adjuvant Radiotherapy in North American Prostate Cancer Patients
Nikola Rakic et al.
CLINICAL GENITOURINARY CANCER (2020)
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
Claire L. Vale et al.
LANCET (2020)
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2020)
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
Andrew Kneebone et al.
LANCET ONCOLOGY (2020)
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
Paul Sargos et al.
LANCET ONCOLOGY (2020)
MR-Guided Radiotherapy for Prostate Cancer
Boris R. Tocco et al.
FRONTIERS IN ONCOLOGY (2020)
Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy
Scott R. Hawken et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
William C. Jackson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark et al.
LANCET (2019)
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H. Brand et al.
LANCET ONCOLOGY (2019)
Phase 1 Trial of SBRT to the Prostate Fossa After Prostatectomy
Leslie K. Ballas et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Amar U. Kishan et al.
JAMA NETWORK OPEN (2019)
Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
Salvina Barra et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E. Spratt et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Indications, Utilization and Complications Following Prostate Biopsy: New York State Analysis
Joshua A. Halpern et al.
JOURNAL OF UROLOGY (2017)
Maximizing resources in the loca ltreatment of prostate cancer: A summaryof cost- effectiveness studies
Vinayak Muralidhar et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity
Sergio Fersino et al.
CLINICAL GENITOURINARY CANCER (2017)
Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer
Stephen L. Lewis et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Pelvic Nodal Dosing With Registration to the Prostate: Implications for High-Risk Prostate Cancer Patients Receiving Stereotactic Body Radiation Therapy
Amar U. Kishan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10
Pirus Ghadjar et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form
Ted A. Skolarus et al.
UROLOGY (2015)
Cost-effectiveness Analysis of SBRT Versus IMRT for Low-risk Prostate Cancer
David J. Sher et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2014)
Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96-02/AUO AP 09/95 Trial
Thomas Wiegel et al.
EUROPEAN UROLOGY (2014)
Early Salvage Radiotherapy Following Radical Prostatectomy
David Pfister et al.
EUROPEAN UROLOGY (2014)
Higher-than-expected Severe (Grade 3-4) Late Urinary Toxicity After Postprostatectomy Hypofractionated Radiotherapy: A Single-institution Analysis of 1176 Patients
Cesare Cozzarini et al.
EUROPEAN UROLOGY (2014)
Hypofractionated IMRT of the Prostate Bed After Radical Prostatectomy: Acute Toxicity in the PRIAMOS-1 Trial
Sonja Katayama et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Quality of life and toxicity after SBRT for organ-confined prostate cancer, a 7-year study
Alan Jay Katz et al.
FRONTIERS IN ONCOLOGY (2014)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial
Edy Ippolito et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
Michel Bolla et al.
LANCET (2012)
Early Hypofractionated Salvage Radiotherapy for Postprostatectomy Biochemical Recurrence
Tim J. Kruser et al.
CANCER (2011)
DEVELOPMENT OF RTOG CONSENSUS GUIDELINES FOR THE DEFINITION OF THE CLINICAL TARGET VOLUME FOR POSTOPERATIVE CONFORMAL RADIATION THERAPY FOR PROSTATE CANCER
Jeff M. Michalski et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2009)
Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy
Gordon W. Wong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
The low α/β ratio for prostate cancer:: What does the clinical outcome of HDR brachytherapy tell
JZ Wang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
JT Wei et al.
UROLOGY (2000)
分享论文
